leisure time -WSS

leisure time

author：hotspot 2025-09-30 00:51:33 - browse：2

Grail spent more than $1 million last quarter lobbying Congress, underscoring the urgency of the company’s bid to secure Medicare coverage for its pricey blood-based cancer screening test that has been on the market for over a year but is not widely used.

A recently posted lobbying report indicates that, during the fourth quarter of last year, the biotech spent $1.07 million on “issues related to oncology and multi-cancer early detection,” including House and Senate bills that would allow Medicare to cover multi-cancer screening tests. That figure has been rising; during the fourth quarter of 2021, the company spent $470,000 on lobbying. That’s far more than cancer and genetic testing biotechs such as Guardant Health, Myriad Genetics, and Tempus, which spent anywhere from $90,000 to nearly $300,000 on lobbying last quarter.

The growing investment in lobbying elected officials comes at a time when Grail is looking to make its test, Galleri, available to a broader swath of the population. The test, launched in 2021, can detect early signs of more than 50 cancers among people who don’t have symptoms. That’s because cancer cells release bits of DNA into the bloodstream, and Galleri spots telltale modifications to this DNA.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

WSS

Infant mortality in U.S. rose last year for first time in decades: CDC

Humans aren't the only ones with an imagination. Rats have it too

The health care issue Democrats can’t solve: hospital reform

Prosecutors say FTX founder Sam Bankman

Pfizer's RSV vaccine recommended for approval in Europe

How to convince healthy people to buy insurance

focus

leisure time

explore

Sports medicine is finally prioritizing gender equality

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Medicare details structure of new drug price negotiation program

'The View' co

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

A new deal aims to ramp up use of AI in rehab care decisions

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Humans aren't the only ones with an imagination. Rats have it too

New air purifier tech could be key to improving indoor air quality

Live blog: Hearing on CRISPR

hotspot

Reframing the conversation around gain

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

Florida babysitter arrested over hot car death, authorities say

Language on climate change, ESG removed from company website of Montana GOP Senate candidate

It's time to take a new tack for treating Alzheimer's

Mega Millions jackpot grows to $720 million ahead of Friday's drawing

entertainment

leisure time

focus

focus